Filter
889
Text search:
pathogen
Featured
133
170
Language
Document type
262
220
212
89
47
25
16
6
4
4
2
1
1
Countries / Regions
54
33
24
23
18
18
16
15
14
13
11
10
9
8
8
8
7
7
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
206
86
85
55
30
22
16
Toolboxes
138
137
68
68
49
48
48
42
22
21
18
17
15
14
13
11
11
9
8
8
8
7
6
1
The Lancet Global Health 2016 Published Online August 30, 2016
http://dx.doi.org/10.1016/S2214-109X(16)30175-9
Globalization and Health201612:53 DOI: 10.1186/s12992-016-0194-4
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
Nosocomial or health-facility-acquired infections are a serious issue, representing one of the most significant causes of morbidity and mortality in healthcare systems and consuming many scarce resources, especially in developing countries. Although much has been done, particularly in the hospital s
...
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
The WHO laboratory biosecurity guidance follows and complements the revision of the Laboratory biosafety manual, fourth edition and provides principles and measures to prevent lapses and incidents throughout the whole value chain of handling high-consequence biological material, technology and infor
...
Health care-associated infections (HAI) are one of the most common adverse events in care delivery and a major public health problem with an impact on morbidity, mortality and quality of life. At any one time, up to 7% of patients in developed and 10% in developing countries will acquire at least on
...
These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences.
The 2018 edition of the guidelines includes the re
...
